Dissecting how gene regulatory redundancy ensures robustness of mammalian development - project summmary/abstract transcriptional enhancers are non-coding DNA elements that control the expression of…
Active Project Grant Awarded Last action
- Award ID
- F31HD118819
- Recipient
-
University Of California Irvine UEI MJC5FCYQTPE6
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $233,528
Award facts
- Assistance listing
- 93.865 Child Health and Human Development Extramural Research
- Completion date 40% complete
- Place of performance
- Irvine, CA 92697, USA
Award details come from USAspending.gov.
About this award
The National Institute of Child Health and Human Development awarded University of California Irvine $233,528 on September 27, 2025, under the Child Health and Human Development Extramural Research (CFDA 93.865) program to support research on gene regulatory redundancy in mammalian development.
The recipient will conduct experimental work to identify distinct transcription factors driving shadow enhancers—redundant non-coding DNA elements that control gene expression during development—and characterize how two shadow enhancers organize in three-dimensional nuclear space during gene activation. Work employs genomic footprinting techniques to determine which transcription factor binding sites are occupied within shadow enhancers during gene activation, complemented by in vivo enhancer-reporter assays to functionally test the requirement of each binding site. The research uses a mouse model of limb morphogenesis and genetic engineering at the GLI3 genomic locus.
Performance takes place in Irvine, California, with a period of performance through June 30, 2028.
Description
Dissecting how gene regulatory redundancy ensures robustness of mammalian development - project summmary/abstract transcriptional enhancers are non-coding DNA elements that control the expression of their target genes with spatiotemporal specificity. Transcription factors confer the specificity of enhancer function by recruiting core transcriptional machinery to the enhancer's target promoter during gene activation. Altered enhancer function may yield a variety of pathologies, including congenital anomalies. However, even under adverse environmental and genetic conditions, most births occur without congenital anomalies, attesting to the resilience of developmental programs. This "developmental robustness" may rely on the fact that most genes expressed during development are controlled by multiple redundant enhancers with overlapping spatiotemporal activities, so-called shadow enhancers. However, despite the ubiquity of these shadow enhancers, we do not completely understand how they confer developmental robustness. Using a mouse model of limb morphogenesis and genetic engineering at the mouse GLI3 genomic locus, I generated preliminary data suggesting that shadow enhancers are activated by distinct transcription factor inputs, despite their apparent redundancy. This "separation of transcription factor inputs" may be significant to shadow enhancers' roles in supporting developmental robustness. The primary objective of this proposal is to identify the distinct transcription factors driving each shadow enhancer (AIM1) and characterize how two distinct shadow enhancers organize in the three-dimensional space of the nucleus during gene activation (AIM2). To achieve aim 1, I will perform a genomic footprinting technique to determine which transcription factor binding sites are occupied within each shadow enhancer during gene activation. This approach will be complemented with an in vivo enhancer-reporter assay to functionally test for the requirement of each binding site. To accomplish aim 2, I will perform three-color DNA fluorescence in situ hybridization (DNA-FISH), which will allow me to measure the CO-localization of two shadow enhancers and the GLI3 promoter under different genetic conditions. The proposed research will unveil the molecular and spatial mechanisms of gene regulatory redundancy during mammalian development. Providing his expertise in gene regulation, mouse transgenics, and developmental biology, DR. Evgeny kvon will serve as my sponsor during the fellowship period. With consultation from DR. Kvon, I have developed a robust training plan to facilitate my transition to becoming an independent investigator and biology educator. Under this proposal, I will learn new skills in genomics, DNA-FISH, transgenics, and bioinformatic analysis. My professional development will encompass training in scientific communication, teaching, and mentorship.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $48,140 | |
| Amendment | $564 | |
| Amendment | $0 | |
| Amendment | $46,206 | |
| Amendment | $0 | |
| Amendment | $46,206 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $46,206 | |
| Amendment | $46,206 | |
| Amendment | $0 | |
| Original award | $0 |
Show all 12
Quick answers
Who received award F31HD118819?
F31HD118819 was awarded to University Of California Irvine by National Institute of Child Health and Human Development (National Institutes of Health) on September 27, 2025.
How much is award F31HD118819 worth?
$233,528 has been obligated on F31HD118819.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award